Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million

/in

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures Darmstadt, Germany, December 8, 2021: Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M Ventures. The new investment of € […]

Read more

Biocomposites Signs Distribution Agreement with NuVasive Specialized Orthopedics to supply STIMULAN® in Germany

/in

STIMULAN® is the first and only calcium matrix approved as an antibiotic carrier for use in bone and soft tissue • Distribution established with leader in German orthopaedic market Keele, UK, 7 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone […]

Read more

ISA to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress

/in

Oegstgeest, December 7, 2021 – ISA’s very own Chief Scientific Officer, Cornelis “Kees” Melief, M.D., Ph.D., will be presenting key learnings in cancer vaccine development in an educational session at the ESMO Immune-Oncology Congress 2021, taking place on 8th – 11th December 2021 in Geneva, Switzerland and online. Read more…

Read more

ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A

/in

Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute First UK-based ATP portfolio company NEW YORK and LONDON, December 7, 2021—ATP (Apple Tree Partners), a leader in life sciences venture capital, today announced the launch of Adendra Therapeutics Ltd. (“Adendra”), a company that will discover and develop treatments for cancers and autoimmune diseases […]

Read more

Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors

/in

Underscores the Company’s ambition to harness the power of ultrasound in precision therapeutics amplification. OSLO/LONDON: 6 DECEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today is delighted to announce the appointment of Anders Wold to its Board […]

Read more
© Optimum Strategic Communications.